UNSPSC 51282326: Erythromycin salnacedin

This classification denotes a macrolide antibiotic with the molecular formula C37H67NO13.C12H13NO5S.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VMA8F29A76, chemically known as erythromycin, compound with n-acetyl-l-cysteine 2-hydroxybenzoate (ester) (1:1), dihydrate, but more generally known as erythromycin salnacedin, which bears US NIH Compound Identifier 60940. European Medicines Agency schedules erythromycin salnacedin or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06605MIG.

UNSPSC 51282326 Erythromycin salnacedin is a Commodity code that represents a specific pharmaceutical product; however, the recent state and local opportunities posted under this code do not align with erythromycin procurement. Instead, the tagged solicitations reflect broader pharmaceutical and medical-supply acquisition activity by state health departments and county public-health agencies. State and local governments use codes in this family to purchase pharmaceutical inventory for emergency preparedness, public-health initiatives, and community health programs. The issuing bodies soliciting under related pharmaceutical codes include state departments of public health, county health departments, and community-health districts procuring through both direct purchase and cooperative-purchasing arrangements such as MMCAP Infuse consortia.

Recent activity shows the Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium (Solicitation 26482DPHPREPDB53392, closed August 28, 2026) for Doxycycline Hyclate and Ciprofloxacin Hydrochloride totaling $2,999,999.11 over the full contract term including renewals; and Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for quarterly delivery to the Seminole County Community Health Building. Geographic activity is centered in the South and Midwest, with Illinois and Florida showing recent solicitation volume. The code itself shows limited direct recent activity—the tagged opportunities reflect pharmaceutical procurement more broadly rather than erythromycin-specific demand, suggesting limited current state and local pursuit of this particular product line.